Treatment with recombinant junctional adhesion molecule-C (JAM-C) which inhibits bone marrow-derived neutrophils (BMDN) apoptosis, could increase the frequences of CXCR4+ aged neutrophils and further exacerbate sepsis-induced lung injury [72]. The gene discussed is JAM3; the disease is Sepsis.